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Dear Sirs,
The Ku (Ku70/Ku80) antigen is a DNA-binding nuclear
protein involved in the repair of double-stranded DNA
breaks by the non-homologous end-joining pathway [1].
Autoantibodies against Ku are infrequently detected and
found in high titers in patients with connective tissue dis-
eases and overlap syndromes [2–4].
In contrast to the low occurrence of anti-Ku antibodies,
peripheral facial nerve palsy (PFNP) is a frequent disorder
of multiple origins that often involves inflammatory
mechanisms [5]. Recently, PFNP has been observed in
three patients with anti-Ku antibodies and systemic auto-
immune disorders [6].
A 40-year-old man suffering from psoriatic arthritis and
a transient PFNP 5 years ago was admitted with weakness
of his right facial muscles and taste disturbances on the
right half of the tongue. Examination revealed weakness of
all facial muscles on the right with incomplete closure of
his right eye. He was unable to frown on his right side.
Rheumatological investigation revealed no signs of vas-
culitis or connective tissue disease. The psoriatic arthritis
was in remission. MRI revealed gadolinium enhancement
and thickening of the right facial nerve (Fig. 1a). Labora-
tory analysis excluded the presence of diabetes mellitus,
infections, vitamin deficiencies, or monoclonal gammopa-
thy, but revealed a high titer of antinuclear antibodies of
1:5,120. Indirect immunofluorescence on human epider-
moid type 2 (HEp-2) cells (Inova, San Diego, CA) showed
patchy nucleoplasmic and nucleolar staining (Fig. 1b),
which prompted us to study the occurrence of anti-Ku
antibodies. The presence of anti-Ku antibodies was con-
firmed by line immunoassay (Imtec, Wiesbaden, Germany)
(Fig. 1b, insert). A stored serum sample obtained from the
patient 7 years earlier also contained anti-Ku antibodies.
Screening for antineuronal antibodies by indirect immu-
nofluorescence on primate cerebellum tissue (The Binding
Site, Birmingham, UK) revealed a similar nuclear staining
pattern as observed in HEp-2 cells, most probably due to
anti-Ku antibodies. Immunoblotting for known neuronal
epitopes, (including Hu, Ri, Yo, CV2, Ma1, Ma2, and
amphiphysin) was negative. While other antinuclear spec-
ificities (anti-SS-A, anti-SS-B, anti-Mi-2, anti-neutrophil
cytoplasmic antibodies, anti-cardiolipin, anti-b2-glycopro-
tein) and anti-ganglioside autoantibodies were negative.
After treatment with 100 mg oral steroids per day over
1 week, the PFNP showed a regression over several weeks.
We describe a patient with recurrent PFNP and high
serum levels of anti-Ku autoantibodies. A potential asso-
ciation of PFNP and anti-Ku antibodies has been postulated
by Gryga et al. [6] in a first report on three patients. The
origin of PFNP is mostly idiopathic or infectious. However,
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a relevant part of cranial neuropathies is caused by
inflammation. Inflammatory cranial neuropathies can be
directly provoked by specific anti-neuronal antibodies as in
Guillain-Barre´ syndrome or Miller-Fisher syndrome [5, 7,
8]. Alternatively, they may evolve from an indirectly
antibody-associated pathogenesis, as in rheumatological
disorders including systemic sclerosis, Sjo¨gren syndrome,
or mixed connective tissue disease [9]. In this light and
given the recent publication of Gryga et al. [6], an asso-
ciation of anti-Ku antibodies and the recurrent PFNP of our
patient seems probable. MRI revealed contrast enhance-
ment in the distal intrameatal and the labyrinthine facial
nerve segment, which is a typical feature in inflammatory
peripheral facial nerve palsy [10–12].
We confirm a potential association of anti-Ku antibodies
and PFNP and extend the observations of Gryga et al. [6] to
patients without overt connective tissue disease. PFNP may
be a leading symptom in patients with high titers of anti-Ku
autoantibodies. It may occur in tandem with myositis,
scleroderma, osteoarticular pain, sicca syndrome, and
Raynaud’s phenomenon [6] or, as in our case, with limited
clinical rheumatological findings. While actually not suf-
fering from a classical connective tissue disease, our
patient did however had a history of psoriasis and thus
signs of a systemic autoimmune disorder. As other anti-
nuclear autoantibody specificities are absent in anti-Ku
positive patients [2], positive antinuclear antibodies
screening tests with a typical pattern on HEp-2 cells should
be followed by specific anti-Ku antibody testing when
PFNP is recurrent or associated with rheumatological
findings. Further systematic testing of patients with PFNP
for anti-Ku antibodies should be performed to search for
more evidence of this possible association in patients with
and without systemic autoimmune diseases.
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facial nerve: MR imaging shows strong enhancement of the right
facial nerve in the distal intrameatal segment 1, the labyrinthine
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ganglion region 3. b Anti-Ku antibodies immunofluorescence: anti-
Ku antibodies revealed by indirect immunofluorescence on HEp-2
substrate cells, demonstrating patchy/homogeneous nucleoplasmic
and nucleolar staining (large image). Specificity for Ku was
confirmed by line-blot immunoassay (insert). Blots were incubated
with serum from a healthy control individual (C) and the patient (P)
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